Vivet Therapeutics
PrivateLast Round
Grant
Feb 1, 2024
Est. Valuation
$340M
Total Funding Raised
$97.36M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vivet Therapeutics is a biotechnology company that develops novel gene therapy treatments for rare, inherited metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivet Therapeutics Comparables
Compare Vivet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 83% | |
| Genespire | 78% | |
| GEMMA Biotherapeutics | 75% | |
Vivet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2024 | ||||
| Strategic | Mar 20, 2019 | ||||
| Series A | May 4, 2017 |
Key People
Founding team and executive leadership
Vivet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series A |
| Idinvest Partners | Series A |
| Ysios Capital | Series A |
| CVJ | Strategic |
| HealthCap | Series A |
| Roche Venture Fund | Series A |
| Pfizer | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 32% MoM to 5.9K.
- Apr 22, 2026
Monthly visitors increased 61% MoM.
Vivet Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivet Therapeutics's valuation, stock price, and market status.